In fact, while anti-viral T cells were slightly more prevalent in the beginning of the immune response, a higher percentage of p15E- and tumor-specific cells than B8R- or virus-specific cells were present over time only in the vvDD-IL15/Rα treatment group coinciding with viral clearance. The gene discussed is IL15; the disease is neoplasm.